Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and N-acetylcysteine for Nicotine Addiction
NCT02723162Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- May 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline and acetylcysteine in nicotine dependence, sponsored by Medical University of South Carolina. Started May 2016; status: completed.
02
Drugs
vareniclineacetylcysteine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02723162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02723162.